Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? (Q37196375)

18 August 2017

1 reference

title

Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? (English)

1 reference

18 August 2017

main subject

phase III clinical trial

0 references

author name string

E Anderson

1

1 reference

18 August 2017

R Grant

2

1 reference

18 August 2017

S C Lewis

3

1 reference

18 August 2017

I R Whittle

4

1 reference

18 August 2017

publication date

1 June 2008

1 reference

British Journal of Neurosurgery

18 August 2017

published in

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

339-349

1 reference

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Surgery for malignant gliomas: mechanistic reasoning and slippery statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Image-guided resection of high-grade glioma: patient selection factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Evaluation of mithramycin in the treatment of anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Superfractionation radiation therapy in the treatment of malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Effects of ACNU and radiotherapy on malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Pion radiation for high grade astrocytoma: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Debulking or biopsy of malignant glioma in elderly people - a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Molecular biology of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Molecularly targeted therapies for malignant gliomas: advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690701885603

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0014-2964(78)90100-7

Identifiers

DOI

10.1080/02688690701885603

1 reference

18 August 2017

1 reference